Completed
The Study of [14C] GZR18
NCT07119450
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +6 more
- Locations
-
- Study site 01 Beijing, China
Clinical trial condition
Overweight
Explore clinical trials studying Overweight. Study availability and eligibility vary by location and protocol.
1,144 public trials
82 recruiting studies
Overweight trial results
NCT00804765
- Conditions
- Body Weight, Childhood Obesity, Nutrition Disorders, +8 more
- Locations
-
- Hôpital Necker Paris, France
NCT06916091
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Lilly Centre for Clinical Pharmacology Singapore
NCT06064006
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- ICON Early Phase Services, LLC San Antonio, Texas, United States
- Novo Nordisk INvestigational Site San Antonio, Texas, United States
Completed
The Impact of Stationary Combined Exercise on Adiponectin and Hs-CRP Levels in Overweight Women
NCT07230873
- Conditions
- Body Weight, Cardiovascular Diseases, Cardiovascular Diseases, Risk Factors, +10 more
- Locations
-
- College of Physical Education and Health Chongqing, China
NCT05981508
- Conditions
- Behavior, Behavior, Animal, Behavior, Eating, +18 more
- Locations
-
- Center for Health Promotion and Disease Prevention Chapel Hill, North Carolina, United States
NCT05211596
- Conditions
- Body Weight, Cardiovascular Risks, Healthy Lifestyle, +8 more
- Locations
-
- National Center for Deaf Health Research, University of Rochester Rochester, New York, United States
Completed
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
NCT07096063
- Conditions
- Body Weight, Cardiovascular (CV) Risk, Diabetes Mellitus, +11 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT06345066
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Fortrea Clinical Research Unit Daytona Beach, Florida, United States
- Fortrea Clinical Research Unit Dallas, Texas, United States
- Fortrea Clinical Research Unit Madison, Wisconsin, United States
Completed
A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity
NCT06976372
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- CenExel Anaheim, California, United States
- CenExel Collaborative Neuroscience Research, LLC Los Alamitos Los Alamitos, California, United States
- Fortrea Clinical Research Unit - Dallas Dallas, Texas, United States